Early Prediction of Objective Response of Fibrinogen in a Real-World Cohort of Hepatocellular Carcinoma Cases Treated by Programmed Cell Death Receptor-1 and Lenvatinib

BACKGROUND: This cohort study aimed to investigate the influence of fibrinogen on progression-free survival and overall survival in unresectable HCC cases treated by PD-1 and lenvatinib. METHODS: A total of 57 unresectable HCC cases who received lenvatinib and PD-1, such as toripalimab, camrelizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yanjun, Wang, Huige, Wei, Jianying, Li, Wendong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513529/
https://www.ncbi.nlm.nih.gov/pubmed/34675546
http://dx.doi.org/10.2147/OTT.S332351
_version_ 1784583226165035008
author Shen, Yanjun
Wang, Huige
Wei, Jianying
Li, Wendong
author_facet Shen, Yanjun
Wang, Huige
Wei, Jianying
Li, Wendong
author_sort Shen, Yanjun
collection PubMed
description BACKGROUND: This cohort study aimed to investigate the influence of fibrinogen on progression-free survival and overall survival in unresectable HCC cases treated by PD-1 and lenvatinib. METHODS: A total of 57 unresectable HCC cases who received lenvatinib and PD-1, such as toripalimab, camrelizumab, or sintilimab, in Beijing Ditan Hospital Affiliated to Capital Medical University were enrolled in this study. RESULTS: Vascular invasion, high FIB (>2.83g/L), and metastasis were highly correlated with low PFS. There was a significant correlation between a raised risk of death and metastasis and increased FIB (>2.83g/L). CONCLUSION: FIB is associated with outcomes of unresectable HCC cases treated by PD-1 and lenvatinib.
format Online
Article
Text
id pubmed-8513529
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85135292021-10-20 Early Prediction of Objective Response of Fibrinogen in a Real-World Cohort of Hepatocellular Carcinoma Cases Treated by Programmed Cell Death Receptor-1 and Lenvatinib Shen, Yanjun Wang, Huige Wei, Jianying Li, Wendong Onco Targets Ther Original Research BACKGROUND: This cohort study aimed to investigate the influence of fibrinogen on progression-free survival and overall survival in unresectable HCC cases treated by PD-1 and lenvatinib. METHODS: A total of 57 unresectable HCC cases who received lenvatinib and PD-1, such as toripalimab, camrelizumab, or sintilimab, in Beijing Ditan Hospital Affiliated to Capital Medical University were enrolled in this study. RESULTS: Vascular invasion, high FIB (>2.83g/L), and metastasis were highly correlated with low PFS. There was a significant correlation between a raised risk of death and metastasis and increased FIB (>2.83g/L). CONCLUSION: FIB is associated with outcomes of unresectable HCC cases treated by PD-1 and lenvatinib. Dove 2021-10-07 /pmc/articles/PMC8513529/ /pubmed/34675546 http://dx.doi.org/10.2147/OTT.S332351 Text en © 2021 Shen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Shen, Yanjun
Wang, Huige
Wei, Jianying
Li, Wendong
Early Prediction of Objective Response of Fibrinogen in a Real-World Cohort of Hepatocellular Carcinoma Cases Treated by Programmed Cell Death Receptor-1 and Lenvatinib
title Early Prediction of Objective Response of Fibrinogen in a Real-World Cohort of Hepatocellular Carcinoma Cases Treated by Programmed Cell Death Receptor-1 and Lenvatinib
title_full Early Prediction of Objective Response of Fibrinogen in a Real-World Cohort of Hepatocellular Carcinoma Cases Treated by Programmed Cell Death Receptor-1 and Lenvatinib
title_fullStr Early Prediction of Objective Response of Fibrinogen in a Real-World Cohort of Hepatocellular Carcinoma Cases Treated by Programmed Cell Death Receptor-1 and Lenvatinib
title_full_unstemmed Early Prediction of Objective Response of Fibrinogen in a Real-World Cohort of Hepatocellular Carcinoma Cases Treated by Programmed Cell Death Receptor-1 and Lenvatinib
title_short Early Prediction of Objective Response of Fibrinogen in a Real-World Cohort of Hepatocellular Carcinoma Cases Treated by Programmed Cell Death Receptor-1 and Lenvatinib
title_sort early prediction of objective response of fibrinogen in a real-world cohort of hepatocellular carcinoma cases treated by programmed cell death receptor-1 and lenvatinib
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513529/
https://www.ncbi.nlm.nih.gov/pubmed/34675546
http://dx.doi.org/10.2147/OTT.S332351
work_keys_str_mv AT shenyanjun earlypredictionofobjectiveresponseoffibrinogeninarealworldcohortofhepatocellularcarcinomacasestreatedbyprogrammedcelldeathreceptor1andlenvatinib
AT wanghuige earlypredictionofobjectiveresponseoffibrinogeninarealworldcohortofhepatocellularcarcinomacasestreatedbyprogrammedcelldeathreceptor1andlenvatinib
AT weijianying earlypredictionofobjectiveresponseoffibrinogeninarealworldcohortofhepatocellularcarcinomacasestreatedbyprogrammedcelldeathreceptor1andlenvatinib
AT liwendong earlypredictionofobjectiveresponseoffibrinogeninarealworldcohortofhepatocellularcarcinomacasestreatedbyprogrammedcelldeathreceptor1andlenvatinib

Ejemplares similares